BioNTech schließt Übernahme von Kites Neoantigen-TCR Zelltherapie-Plattform und Produktionsanlagen im amerikanischen Gaithersburg ab MAINZ, Deutschland & Santa Monica, USA, 4. August 2021 – BioNTech SE (Nasdaq: BNTX, „BioNTech”) und Kite, ein Unternehmen der Gilead-Gruppe (Nasdaq: GILD, „Kite”) gaben heute bekannt, dass...

BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland MAINZ, Germany & Santa Monica, USA, August 4, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the closing of the acquisition of the...

IBD Announces First Annual Biotech Innovator Awards Biogen, Celgene, Incyte, Kite Pharma, Loxo Oncology, and Regeneron Pharmaceuticals recognized for outstanding contributions to science and patient health Companies driving advancements to cure...

Distinguished Life Sciences Leaders to be Honored at CLSA's 2015 Pantheon DiNA Awards Ceremony SOUTH SAN FRANCISCO, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), the leading voice to drive innovation for California's life sciences sector, today announced...